However, a combination of PD-1 blockade with vaccination demonstrated PSA response in patients and an induction of PAP-specific immunity associated with a decline of PSA levels and increased tumor infiltrating CD8+ T cells. The gene discussed is CD8A; the disease is neoplasm.